Combination Vaccine Manufacturers, Suppliers & Companies
-
Manufacturerbased in Kumamoto, JAPAN
At KM Biologics, we are driven by our mission of making the world a healthier place through the unlimited possibilities of biotechnology. Through our three main areas of business, KM Biologics supplies first-rate biological products and services ...
KMB - Quattrovac Combined Vaccine
In additions to protective antigens against Bordetella pertussis, diphtheria toxoid and tetanus toxoid, Quattrovac also contains inactivated poliovirus types 1, 2 and 3 derived from Sabin strains. Quattrovac does not contain thimerosal or other ...
CONTACT SUPPLIER -
Manufacturerbased in Bilthoven, NETHERLANDS
Bilthoven Biologicals produces various products such as polio, diphtheria tetanus polio combination vaccine (DT-IPV), tetanus vaccines and BCG for the treatment of bladder cancer. At BBio we are working on developing vaccines that give our world ...
Bilthoven - Model DT-IPV - Combination Vaccine
The DT-IPV combination vaccine (diphteria, tetanus and poliomyelitis) can be used as the first (primary) inoculation, or as a booster vaccination. The Dutch Vaccination Program ...
CONTACT SUPPLIER -
Manufacturerbased in Cambridge, MASSACHUSETTS (USA)
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. ...
-
Manufacturerbased in Taipei City, TAIWAN
Founded in 2021, ImmunAdd, Inc., is a privately held biopharmaceutical company on a mission to improve health through advances in adjuvant design and formulation. We are developing next generation saponin adjuvants and using them as the basis for ...
Immunadd - Model IA-05 - Saponin-Based Adjuvant
IA-05 is a truncated QS-21 analogue with improved tolerability, stability, and long-term immune responses in combination of various antigens. IA05 is expected to lead novel utilities in development of immunotherapies and therapeutic ...
CONTACT SUPPLIER -
Manufacturerbased in Oxford, UNITED KINGDOM
Oxford Vacmedix was established in 2012 as a spinout from Oxford University. Its aim is to develop therapeutic agents for the treatment of cancer based on the invention of Professor Shisong Jiang – Recombinant Overlapping Peptides (ROP). These ...
-
Manufacturerbased in Abingdon, UNITED KINGDOM
Emergex Vaccines is a clinical-stage, privately held biotechnology company headquartered near Oxford, UK, with R&D facilities in Milton Park, UK and an operating subsidiary in Doylestown, Pennsylvania, USA. Emergex Vaccines is focussed on developing ...
-
Manufacturerbased in Gaithersburg, MARYLAND (USA)
We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. We have more than a decade of experience contending with ...
Novavax - Model RSV F - Combination Seasonal Influenza Vaccine
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations ...
CONTACT SUPPLIER -
Manufacturerbased in County of New Castle, DELAWARE (USA)
MedGenome Inc. is a global leader in personalized medicine with unique genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Founded in 2013, MedGenome currently has a Next Generation Sequencing (NGS) ...
-
Manufacturerbased in Seattle, WASHINGTON (USA)
Icosavax is dedicated to advancing vaccines against severe life-threatening respiratory diseases to protect our most at-risk populations. We are committed to developing safe and effective vaccines against infectious diseases that address important ...
Icosavax - Model IVX-A12 - RSV/hMPV Bivalent VLP Vaccine Candidate
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. ...
CONTACT SUPPLIER -
Manufacturerbased in Auburn, ALASKA (USA)
SiO2 Materials Science is focused on three core segments: Pharmaceuticals, Molecular Diagnostics, and Consumer Healthcare. In the pharma segment, we solve more than 30 problems“ including some of the most challenging related to drug stability, drug ...
-
Manufacturerbased in Baldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
VicOryx - Model p16 - Therapeutic Vaccine
of HR-HPV-mediated cell transformation. About 5% of all cancers are associated with HR-HPV including virtually all cervical cancers, 85-95% of anal and vulvar cancers, 20-40% of vaginal and penile cancers and 30-60% of head and neck cancers. ...
CONTACT SUPPLIER -
Manufacturerbased in Uppsala, SWEDEN
Abera Bioscience is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from the Swedish protein production company Xbrane ...
-
Manufacturerbased in Nantes, FRANCE
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics ...
Tedopi - Neo-Epitope-Based Vaccine
Tedopi®, OSE Immunotherapeutics’s most advanced product and therapeutic neo-epitope-based vaccine, is a proprietary combination of nine optimized neo-epitopes, selected and optimized from 5 tumoral ...
CONTACT SUPPLIER -
Manufacturerbased in Paris, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
Enterome - Model OncoMimics - Therapeutic Cancer Vaccines
OncoMimicsTM vaccines are a specific combination of bacterial peptides, derived from bacteria present in the gut microbiome, that closely mimic either overexpressed tumor-associated antigens (TAAs) or ...
CONTACT SUPPLIER -
Service providerbased in Astoria, NEW YORK (USA)
We develop immune system modulators that activate and direct the most powerful immune cells in the body for targeted responses to disease. Our underpinning science originates from two of New Zealand’s leading research institutes, the Ferrier ...
Avalia - Model AVA2300 - Influenza Prevention Vaccine
Influenza severely affects over 3 million people annually and results in up to 650,000 deaths annually from the associated respiratory diseases caused by seasonal influenza. Due to frequent mutations of the influenza virus, current strain-specific ...
CONTACT SUPPLIER -
Manufacturerbased in Pearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
Auro - Model PBS VAX - Preclinical-Stage Therapeutic Vaccines for HBV
Auro Vaccines has also developed a GeneVax prime/VesiculoVax boost therapeutic vaccine that targets all eight HBV genotypes for use as an adjunct to drug ...
CONTACT SUPPLIER -
Manufacturerbased in Oxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
Moditope - Model Modi-1 - Cancer Vaccine
Modi-1 is the first vaccine based on Scancell’s Moditope® platform. The vaccine is composed of a combination of three peptides from two target antigens that are commonly modified in cancer ...
CONTACT SUPPLIER -
Manufacturerbased in NY, NEW YORK (USA)
As a global Contract Research Organization (CRO), headquartered in New York, USA, Alfa Chemistry has served the pharmaceutical and biotechnology industries for years. Today, Alfa Chemistry is specialized in organic chemistry, material chemistry, and ...
Alfa Chemistry - Vaccine Stabilizers
is a critical means of maintaining vaccine potency and efficiency. Such stabilizers stop chemical reactions from occurring in the vaccine and prevent the components from separating from each other or sticking to ...
CONTACT SUPPLIER -
Technologybased in Lynnwood, WASHINGTON (USA)
Kurve Therapeutics drug delivery technology is designed to target the most difficult part of the treatment process - getting medication through the blood-brain barrier and into the brain. Kurve Therapeutics has 18 peer-reviewed publications of ...
-
Manufacturerbased in Olathe, KANSAS (USA)
TVAX Biomedical is a clinical stage development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. TVAX Biomedical is developing a paradigm-shifting cancer treatment that offers the promise of improved ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you